• Distinguishing Proliferation Arrest from Cell Death in In Vi

  2026-06-11

  Schwartz's dissertation redefines how in vitro anti-cancer drug responses are measured by separating relative viability from fractional viability, clarifying the distinct effects of drugs on proliferation and apoptosis. This approach enables more precise assessment of compounds like pan-Bcl-2 inhibitors and informs the design of preclinical cancer research assays.

• Formononetin Preserves Chemotherapy Efficacy While Preventin

  2026-06-11

  This study identifies formononetin as a neuroprotective agent that prevents oxaliplatin-induced peripheral neurotoxicity via activation of the Nrf2/HO-1 antioxidant pathway, without reducing the anticancer efficacy of oxaliplatin or paclitaxel. The findings address a critical gap in chemotherapy-induced peripheral neuropathy management, suggesting a new strategy for enhancing patient quality of life during cancer treatment.

• Verapamil HCl: Mechanistic Leverage from Calcium Channels to

  2026-06-10

  This thought-leadership article examines how Verapamil HCl, traditionally known as an L-type calcium channel blocker, is reshaping translational research from oncology and inflammation to osteoporosis. By integrating mechanistic evidence—particularly around TXNIP modulation and the ChREBP axis—the piece delivers strategic guidance for translational scientists. It references recent high-impact studies, protocol recommendations, and comparative perspectives, while anchoring product intelligence from APExBIO. This article uniquely bridges cross-domain applications and highlights emerging competitive advantages for researchers advancing from cellular models to clinical translation.

• (R,S)-Anatabine: Precision Tool for Amyloid-β Pathway Studie

  2026-06-10

  (R,S)-Anatabine is an advanced research compound for Alzheimer's disease, uniquely enabling precise modulation of amyloid-β and inflammatory pathways. Explore new mechanistic insights and practical protocols that distinguish this molecule in neurodegeneration research.

• Taxus chinensis Fruit Extract Suppresses Neuroinflammation v

  2026-06-09

  This study demonstrates that Taxus chinensis fruit extract (TCFE) attenuates aging-related behavioral and neuroinflammatory changes by inhibiting microglial activation through the TLR4/NF-κB/NLRP3 pathway. The findings establish a mechanistic basis for TCF's anti-inflammatory potential and provide a framework for translational research in neuroinflammation and aging.

• Amyloid β-Peptide (1-42) (human): Assay Reliability & Protoc

  2026-06-09

  This article addresses key laboratory questions on using Amyloid β-Peptide (1-42) (human), SKU B6057, for neurotoxicity and microglial clearance assays. Through scenario-driven Q&A, we evaluate reproducibility, solubility, data interpretation, and vendor selection, highlighting evidence-based protocols and comparative advantages for Alzheimer's disease research.

• LY2886721: Precision BACE1 Inhibition for Neuroprotection Re

  2026-06-08

  Explore how LY2886721, a potent BACE inhibitor, enables targeted amyloid beta reduction while preserving synaptic function. This article delivers advanced scientific insight for researchers seeking nuanced control in Alzheimer's disease models.

• Cell Death Mechanisms and Clinical Impact in Liver Disease

  2026-06-08

  This review dissects the molecular mechanisms and clinical relevance of hepatocyte death in liver disease, emphasizing its role as both a biomarker and a driver of progression. The findings clarify how apoptosis, necrosis, and necroptosis contribute to pathology, with implications for diagnostic and therapeutic strategies.

• Gemcitabine HCl: Mechanistic Insights and Optimized Preclini

  2026-06-07

  Explore how Gemcitabine HCl, a potent DNA synthesis inhibitor, enables nuanced tumor suppression and apoptosis induction in advanced pancreatic cancer models. This article uniquely integrates mechanistic analysis and protocol optimization, highlighting insights from multianimal MRI studies.

• Technical Use of HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-06-06

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for efficient, reproducible synthesis of Cy3-labeled RNA probes for research applications such as in situ hybridization and Northern blotting. It is not intended for diagnostic or clinical workflows, and is designed to streamline sensitive fluorescent RNA probe generation in standard research laboratories.

• Mechanisms of Spiroplasma eriocheiris Entry in Drosophila S2

  2026-06-05

  This study elucidates the cellular entry pathways of Spiroplasma eriocheiris in Drosophila Schneider 2 cells, revealing a reliance on clathrin-mediated endocytosis, macropinocytosis, and an intact cytoskeleton. The findings refine our understanding of host-pathogen interactions in invertebrate models and highlight experimental strategies for dissecting infection mechanisms.

• GSK621: Advanced AMPK Agonist Workflows for AML and Immunome

  2026-06-05

  GSK621 is redefining experimental design in acute myeloid leukemia and immunometabolic research by delivering potent, selective AMPK activation with translational impact. Unlock stepwise protocols, comparative advantages, and troubleshooting strategies that empower reproducible results and deeper mechanistic insight.

• Angiotensin I (human, mouse, rat): Decoding Sequence, Functi

  2026-06-04

  Explore the Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu sequence of Angiotensin I and its pivotal role as a research tool in renin-angiotensin system studies. This article uniquely analyzes peptide structure–function insights, translational assay considerations, and recent discoveries linking angiotensin peptides to viral binding.

• L-Glutathione Reduced: Optimizing Redox and Cancer Research

  2026-06-04

  L-Glutathione Reduced from APExBIO empowers researchers to dissect redox balance and metabolic reprogramming in cancer, offering reproducible results in oxidative stress and GST assays. This guide distills experimental best practices, troubleshooting tips, and the impact of GOT1 inhibition studies to maximize outcomes in advanced bioscience labs.

• Structural and Chemical Advances in Silybin for Hepatoprotec

  2026-06-03

  The reference review systematically dissects the chemistry, structural elucidation, and derivatization of Silybin—the principal active of Silymarin—over five decades of research. Its breakthroughs in stereochemical resolution, synthesis, and functional modification provide the foundation for modern studies in hepatoprotective and metabolic enzyme modulation, setting precise chemical standards for experimental reproducibility.

478 records 10/32 page Previous Next First page 上5页 678910 下5页 Last page